posted
The Rumor is that MSNC or FOX News will be doing special coverage this week on the Multiple Schlerosis drug Fempridine. This will no doubt have a huge effect on the PPS. Its continued its upwards trend movement due to consecutive analysts upgrade recommendations.
The Phat Man
posted
quote:Originally posted by Lootcifer: The Rumor is that MSNC or FOX News will be doing special coverage this week on the Multiple Schlerosis drug Fempridine. This will no doubt have a huge effect on the PPS. Its continued its upwards trend movement due to consecutive analysts upgrade recommendations.
where'd ya hear this loot? i grew some balls and pulled the trigger on this at 7.20 and it's been one of the better plays i've been in in awhile. know anything about expected FDA approval date?
invester
posted
I bought at $11. Also look at DVAX.
invester
posted
Can you say freight train.
JRK
posted
How far is ACOR going to rocket? After doing my DD i am still skidish about getting in at the 15-16 range...
invester
posted
I sold at $16.60.
invester
posted
I rebought at $14.50
wadeinni
posted
quote:Originally posted by invester: I rebought at $14.50
This in my opinion is the best way to play ACOR right now. It does very crazy fluctuations when it dips and rises. Try buying at the very lowest point during the day and flip it near the high of day. IMO it will reach the $20's soon but I wouldn't recommend buying and holding till that PPS, way to volatile. GLTA
invester
posted
19m shares out at $2o is roughly $400m. This is a multi billion dollar drug. With a P/E of even 5 we are WAY into the $100 range. I think you are low balling a little. This is a keeper. ACTC should run well over $10 also when the government appropriations come in.
posted ![[Smile]](smile.gif)